Collaborative training program boosts Alzheimer’s biomarker research
An estimated 5.4 million Americans currently live with Alzheimer’s disease, a number that is expected to triple by 2050. One of the most promising methods for defining the disease’s causes and progression is to identify biomarkers, or biological indicators of the disease, in the human brain. But more cross-disciplinary efforts are needed